Antiemetic guidelines for low and moderately low emetogenic potential chemotherapy

Perez EA Comparative efficacy of oral and intravenous granisetron for the prevention of acute chemotherapy-induced emesis. Clin Ther. 1996;18:578-590.

The Italian Group for Antiemetic Research. Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N Engl J Med. 1995;332:1-5.

Kris MG , Baltzer L. , Pisters Kmw , Tyson LB Enhancing the effectiveness of the specific serotonin antagonists: combination antiemetic therapy with dexamethasone. Cancer. 1993;72:3436-3442.

Gonzales J. Antiemetic agents used in cancer chemotherapy patients. Pharmacy Practice News. 1998.

Memorial Sloan-Kettering Cancer Center. Antiemetic regimens based on the emetic potential of specific chemotherapy programs. 1995.

Ettinger DS , Huber S. , Kris MG , et al. NCCN antiemesis practice guidelines. Oncology. 1997;11:57- 89.

Nolte MJ , Berkery R. , Pizzo B. , et al. Assuring the optimal use of serotonin antagonist antiemetics: the process for development and implementation of institutional antiemetic guidelines at Memorial Sloan-Kettering Cancer Center. J Clin Oncol. 1998;16:771-778.